Stocks and Investing Stocks and Investing
Tue, January 29, 2019
Mon, January 28, 2019
Fri, January 25, 2019
Thu, January 24, 2019

Joseph Schwartz Upgraded (ASND) to Buy and Increased Target to $90 on, Jan 24th, 2019


Published on 2024-10-26 11:55:07 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Upgraded "Ascendis Pharma A/S" (ASND) to Buy and Increased Target from $73 to $90 on, Jan 24th, 2019.

Joseph, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources